These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16697272)

  • 61. [The changes in serum enzyme in non-A, non-B hepatitis].
    Yoshiba M
    Nihon Rinsho; 1988 Dec; 46(12):2639-44. PubMed ID: 3149336
    [No Abstract]   [Full Text] [Related]  

  • 62. Safety of statin therapy in HIV/hepatitis C virus-coinfected patients.
    Milazzo L; Menzaghi B; Corvasce S; Bonfanti P; Rusconi S; Ridolfo AL; Antinori S
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):258-60. PubMed ID: 17895771
    [No Abstract]   [Full Text] [Related]  

  • 63. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
    Isa SE; Ebonyi AO; Shehu NY; Idoko P; Anejo-Okopi JA; Simji G; Odesanya RU; Abah IO; Jimoh HO
    Int J Mycobacteriol; 2016 Mar; 5(1):21-6. PubMed ID: 26927986
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association Between Statin Use, Intensity and Acute Liver Injury in Human Immunodeficiency Virus, Hepatitis C Virus, and Uninfected US Veterans.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):103-112. PubMed ID: 32239436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Chronic active non-A, non-B hepatitis].
    Moreira Vicente VF; Barcena Marugán R; Hernández Ranz F; Milicua Salamero JM; Martín Scapa MA; Ruiz del Arbol L; Bueno Vallejo R; Gil Grande LA; Suárez García E; García Plaza A
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):270-86. PubMed ID: 6419304
    [No Abstract]   [Full Text] [Related]  

  • 66. Significance of repeatedly normal aminotransferase activities in hepatitis C virus-infected patients.
    Zylberberg H; Nalpas B; Brechot C; Berthelot P
    Hepatology; 1998 Apr; 27(4):1169. PubMed ID: 9537462
    [No Abstract]   [Full Text] [Related]  

  • 67. [Special recommendations for lipid-lowering treatment: efficacy and safety].
    Martinez TL; Nascimento HM
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():6-8. PubMed ID: 16400389
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
    Byrne DD; Tate JP; Forde KA; Lim JK; Goetz MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Bedimo R; Freiberg MS; Justice AC; Kostman JR; Roy JA; Lo Re V
    Clin Infect Dis; 2017 Oct; 65(9):1542-1550. PubMed ID: 29020184
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Elevated Liver Enzymes Unmask Severe Statin-Induced Muscle Injury.
    Abdallah MA; Ahmed KM; Gohar A; Abdalla AO; Waqas Q; Elgouhari H; Huntington MK
    Am J Ther; 2020; 27(4):e420-e422. PubMed ID: 31180927
    [No Abstract]   [Full Text] [Related]  

  • 70. Retrospective evaluation of the effect of valproate therapy on transaminase elevations in patients with hepatitis C.
    Lott RS; Helmboldt KM; Madaras-Kelly KJ
    Pharmacotherapy; 2001 Nov; 21(11):1345-51. PubMed ID: 11714207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
    McKenney JM; Davidson MH; Jacobson TA; Guyton JR;
    Am J Cardiol; 2006 Apr; 97(8A):89C-94C. PubMed ID: 16581336
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Increased transaminases but usual hepatitis diagnosis is negative. Immune system as liver killer?].
    Stiefelhagen P
    MMW Fortschr Med; 2002 Oct; 144(43):10. PubMed ID: 12534008
    [No Abstract]   [Full Text] [Related]  

  • 73. Impact of statins on nephrolithiasis in hyperlipidemic patients: a 10-year review of an equal access health care system.
    Sur RL; Masterson JH; Palazzi KL; L'Esperance JO; Auge BK; Chang DC; Stoller ML
    Clin Nephrol; 2013 May; 79(5):351-5. PubMed ID: 23195830
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical chemistry of chimpanzees. I. Determination of aminotransferase baseline values for hepatitis studies.
    Valenza FP; Muchmore E
    J Med Primatol; 1982; 11(6):342-51. PubMed ID: 6153021
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Statin-induced hepatotoxicity.
    Kaplowitz N
    Gastroenterology; 2004 Oct; 127(4):1278; author reply 1278-9. PubMed ID: 15481021
    [No Abstract]   [Full Text] [Related]  

  • 76. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
    Russo MW; Hoofnagle JH; Gu J; Fontana RJ; Barnhart H; Kleiner DE; Chalasani N; Bonkovsky HL
    Hepatology; 2014 Aug; 60(2):679-86. PubMed ID: 24700436
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.
    Chojnacki C; Błońska A; Chojnacki J
    Biomed Res Int; 2017; 2017():3204504. PubMed ID: 28630863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice.
    Kim H; Lee H; Kim TM; Yang SJ; Baik SY; Lee SH; Cho JH; Lee H; Yim HW; Choi IY; Yoon KH; Kim HS
    Cardiovasc Ther; 2018 Jun; 36(3):e12324. PubMed ID: 29464863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Liver biochemistry abnormalities in a quaternary care lipid clinic database.
    Wiesinger HA; Shah J; White A; Yoshida EM; Frohlich J; Sirrs S; Gill S; Byrne MF
    Ann Hepatol; 2008; 7(1):63-6. PubMed ID: 18376368
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Statin-induced liver injury in an area endemic for hepatitis B virus infection: risk factors and outcome analysis.
    Wang LY; Huang YS; Perng CL; Huang B; Lin HC
    Br J Clin Pharmacol; 2016 Sep; 82(3):823-30. PubMed ID: 27197051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.